RTX posted impressive fourth-quarter 2024 results, surpassing analyst expectations and demonstrating significant growth ...

For the quarter that ended on Dec. 31, F5 reported adjusted earnings per share of $3.84, up from $3.43 in the same quarter of the previous year, on revenue of $766 million, up 10.53% year-over-year.

Zee's ad revenue declined to Rs 940 crore. Domestic ad revenue came in at Rs 880 crore, down 10.8 percent YoY as softness in the overall ad environment continued ...

Detailed price information for Taiwan Semiconductor ADR (TSM-N) from The Globe and Mail including charting and trades.

We recently compiled a list of the 10 Best Australian Stocks to Buy Now. In this article, we are going to take a look at ...

Detailed price information for American Express Company (AXP-N) from The Globe and Mail including charting and trades.

Icertis, the global leader in AI-powered contract intelligence, was named a winner in the 2025 BIG Innovation Awards, presented by the Business Intelligence Group. This recognition highlights the ...

While these figures missed expectations, they did grow year over year. Also, overall organic ... JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary ...

In an earnings call, Zee CEO Punit Goenka says Zee is actively identifying gaps and developing innovative solutions to enhance its competitive advantage ...

Barclays (LON: BARC) trimmed its Apple (NASDAQ: AAPL) estimates on Wednesday, citing potential risks of the company missing ...

GRAFAPEX™ (treosulfan) for injection is approved by the FDA for sale and use in the United States only and is not intended for export outside the United States. Medexus makes no representation that ...